ALNYLAM PHARMACEUTICALS, INC. Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALNYLAM PHARMACEUTICALS, INC. for January 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 27 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | M | 31.39 | 15,000 | 470,850 | 0 | |
Jan 27 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 37.95 | 15,000 | 569,250 | 140,795 | 155.8 K to 140.8 K (-9.63 %) |
Jan 27 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | M | 31.39 | 15,000 | 470,850 | 155,795 | 140.8 K to 155.8 K (+10.65 %) |
Jan 20 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | M | 15.91 | 15,000 | 238,650 | 0 | |
Jan 20 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 38.20 | 6,200 | 236,840 | 140,795 | 147 K to 140.8 K (-4.22 %) |
Jan 20 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 37.57 | 8,800 | 330,616 | 146,995 | 155.8 K to 147 K (-5.65 %) |
Jan 20 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | M | 15.91 | 15,000 | 238,650 | 155,795 | 140.8 K to 155.8 K (+10.65 %) |
Jan 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 18.66 | 1,340 | 25,004 | 144,641 | |
Jan 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 18.66 | 1,340 | 25,004 | 149,710 | 148.4 K to 149.7 K (+0.90 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 21.35 | 4,356 | 93,001 | 55,994 | |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 18.66 | 4,019 | 74,995 | 45,981 | |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 16.43 | 1,172 | 19,256 | 38,913 | |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Payment of Exercise | F | 37.44 | 5,000 | 187,200 | 10,297 | 15.3 K to 10.3 K (-32.69 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 21.35 | 4,356 | 93,001 | 15,297 | 10.9 K to 15.3 K (+39.81 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 18.66 | 4,019 | 74,995 | 10,941 | 6.9 K to 10.9 K (+58.06 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 16.43 | 1,172 | 19,256 | 6,922 | 5.8 K to 6.9 K (+20.38 %) |
Jan 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 0.00 | 8,502 | 0 | 8,502 |